![Robert McDowell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert McDowell
Keine laufenden Positionen mehr
Profil
Robert Scott McDowell hat die Position des Chief Scientific Officer bei MyoKardia, Inc. inne. Zuvor war er Vice President-Research bei Sagimet Biosciences, Inc. und Senior Scientist bei Genentech, Inc. sowie Vice President-Research bei Sunesis Pharmaceuticals, Inc. und Director-Structural Chemistry bei Axys Pharmaceuticals, Inc. Er erwarb einen Bachelor-Abschluss an der Butler University und einen Doktortitel an der University of California, Berkeley.
Ehemalige bekannte Positionen von Robert McDowell
| Unternehmen | Position | Ende |
|---|---|---|
| MYOKARDIA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2020 |
| SAGIMET BIOSCIENCES INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2012 |
| VIRACTA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 04.08.2008 |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers integrated drugs | Corporate Officer/Principal | 01.01.2000 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1999 |
Ausbildung von Robert McDowell
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers integrated drugs | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Butler University
 Butler University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
